Showing results (521-530 of 3,965) with videos related to

Sort By:
Pageof 397
Translational Cancer Research|September 12, 2022
Extracranial metastasis of glioblastoma with genomic analysis: a case report and review of the literatureMei Chai, Qingming Shi
Translational Cancer Research|September 12, 2022
Complete response by patients with advanced hepatocellular carcinoma after combination immune/targeted therapy and transarterial chemoembolization: two case reports and literature reviewXiang Nong, Yu-Mei Zhang, Jing-Chang Liang, et al.
Translational Cancer Research|September 12, 2022
Development of multivariable risk signature based on four immune-related RNA-binding proteins to predict survival and immune status in lung adenocarcinomaQingsheng You, Hao Shen
Translational Cancer Research|September 12, 2022
Diagnosis and prognostic analysis of skin infiltration in chronic lymphocytic leukemia: a case report and literature reviewXiangyu Zhao, Ting Li, Piaoying Wang, et al.
Translational Cancer Research|August 15, 2022
Comparative study of sarcomatoid carcinoma and carcinosarcoma of the pancreas: a population-based studyXinchun Liu, Haoran Wang, Rongchao Ying
Translational Cancer Research|August 15, 2022
Pneumocystis jirovecii pneumonia in non-Hodgkin's lymphoma after rituximab-based chemotherapy: a case seriesQianying Zhang, Liang Han, Yuanyuan Lin, et al.
Translational Cancer Research|August 15, 2022
Diagnosis accuracy of the miR-200 family tumor marker series in ovarian cancer: a systematic review and meta-analysisLi Liu, Pan Li, Qin Wang, et al.
Translational Cancer Research|August 15, 2022
Integrated analysis of multiple bioinformatics studies to identify microRNA-target gene-transcription factor regulatory networks in retinoblastomaYanjun Wen, Maolin Zhu, Xuerui Zhang, et al.
Translational Cancer Research|August 15, 2022
A multiomic ferroptosis-associated prognostic signature incorporating epigenetic and transcriptional biomarkers for hepatocellular carcinomaJida Chen, Xinli Zhu, Danzhi Chen, et al.
Translational Cancer Research|August 15, 2022
Value of postoperative radiotherapy for stage IIIa-N2 non-small cell lung cancer: an analysis based on SEER databaseRan Yang, Jun Gong, Zhengkai Liao, et al.
Pageof 397